Cargando…

Protection by hydroxychloroquine prevents placental injury in obstetric antiphospholipid syndrome

Obstetric antiphospholipid syndrome (OAPS) is mediated by antiphospholipid antibodies (aPLs, and anti‐β2 glycoprotein I antibody is the main pathogenic antibody), and recurrent abortion, preeclampsia, foetal growth restriction and other placental diseases are the main clinical characteristics of pla...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Jing, Zhang, Liting, Tian, Yijia, Wan, Shuting, Hu, Min, Song, Shasha, Zhang, Meihua, Zhou, Qian, Xia, Yu, Wang, Xietong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344817/ https://www.ncbi.nlm.nih.gov/pubmed/35770338 http://dx.doi.org/10.1111/jcmm.17459

Ejemplares similares

Antiphospholipid antibody‐activated NETs exacerbate trophoblast and endothelial cell injury in obstetric antiphospholipid syndrome
por: Lu, Yuan, et al.
Publicado: (2020)

Obstetric antiphospholipid syndrome
por: Antovic, Aleksandra, et al.
Publicado: (2018)

Hydroxychloroquine as an Immunomodulatory and Antithrombotic Treatment in Antiphospholipid Syndrome
por: Arachchillage, Deepa J., et al.
Publicado: (2023)

Natural killer cells in obstetric antiphospholipid syndrome
por: Huo, Rongxiu, et al.
Publicado: (2022)

Urine Proteomics Differentiate Primary Thrombotic Antiphospholipid Syndrome From Obstetric Antiphospholipid Syndrome
por: Zhou, Zhuochao, et al.
Publicado: (2021)

Differences in Antiphospholipid Antibody Profile between Patients with Obstetric and Thrombotic Antiphospholipid Syndrome
por: Anunciación-Llunell, Ariadna, et al.
Publicado: (2022)

6-Gingerol alleviates placental injury in preeclampsia by inhibiting oxidative stress via BNIP3/LC3 signaling-mediated trophoblast mitophagy
por: Li, Anna, et al.
Publicado: (2023)

Exosomal miR-146a-5p derived from human umbilical cord mesenchymal stem cells can alleviate antiphospholipid antibody-induced trophoblast injury and placental dysfunction by regulating the TRAF6/NF-κB axis
por: Lv, Qingfeng, et al.
Publicado: (2023)

Obstetric Antiphospholipid Syndrome From the Perspective of a Rheumatologist
por: Santacruz, Juan Camilo, et al.
Publicado: (2022)

Seronegative Obstetric Antiphospholipid Syndrome Finally Treated Successfully
por: Alghanim, Khawla K, et al.
Publicado: (2022)

Obstetric antiphospholipid syndrome: Number 6 - June 2021
por: Barros, Venina Isabel Poço Viana Leme de, et al.
Publicado: (2021)

Obstetrical Antiphospholipid Syndrome: From the Pathogenesis to the Clinical and Therapeutic Implications
por: Marchetti, T., et al.
Publicado: (2013)

Obstetric Antiphospholipid Syndrome: An Approach from Glycans of the Immunoglobulin G
por: Alvarez, Angela María, et al.
Publicado: (2021)

Hydroxychloroquine partially prevents endothelial dysfunction induced by anti-beta-2-GPI antibodies in an in vivo mouse model of antiphospholipid syndrome
por: Urbanski, Geoffrey, et al.
Publicado: (2018)

The role of hydroxychloroquine in catastrophic antiphospholipid syndrome case: Series of two case reports and review of literature
por: Hindi, Zakaria, et al.
Publicado: (2018)

Efficacy of Hydroxychloroquine for Improving Pregnancy Outcomes in a Female with Systemic Lupus Erythematosus and Antiphospholipid Syndrome
por: Takaki, Yumika, et al.
Publicado: (2022)

Pathogenesis, Diagnosis and Management of Obstetric Antiphospholipid Syndrome: A Comprehensive Review
por: Alijotas-Reig, Jaume, et al.
Publicado: (2022)

Long Term Follow up of Patients With Primary Obstetric Antiphospholipid Syndrome
por: Niznik, Stanley, et al.
Publicado: (2022)

Management of thrombotic and obstetric antiphospholipid syndrome: a systematic literature review informing the EULAR recommendations for the management of antiphospholipid syndrome in adults
por: Tektonidou, Maria G, et al.
Publicado: (2019)

Early Prediction of Adverse Pregnancy Outcome in Women with Systemic Lupus Erythematosus, Antiphospholipid Syndrome, or Non-Criteria Obstetric Antiphospholipid Syndrome
por: Baños, Núria, et al.
Publicado: (2022)

Hemorrhage complications in obstetric antiphospholipid syndrome: Risk factors and association with adverse pregnancy outcomes
por: Luo, Yongjing, et al.
Publicado: (2023)

Comparison of treatments for the prevention of fetal growth restriction in obstetric antiphospholipid syndrome: a systematic review and network meta-analysis
por: Urban, Maria Letizia, et al.
Publicado: (2021)

Obstetric antiphospholipid syndrome: early variations of angiogenic factors are associated with adverse outcomes
por: Cochery-Nouvellon, Éva, et al.
Publicado: (2017)

Thrombocytopenia in the first trimester predicts adverse pregnancy outcomes in obstetric antiphospholipid syndrome
por: Jin, Jiayang, et al.
Publicado: (2022)

Identification and ultrasensitive photoelectrochemical detection of LncNR_040117: a biomarker of recurrent miscarriage and antiphospholipid antibody syndrome in platelet-derived microparticles
por: Sun, Zhiwei, et al.
Publicado: (2022)

Clinical characteristics and prognosis of patients with isolated thrombotic vs. obstetric antiphospholipid syndrome: a prospective cohort study
por: Jiang, Hui, et al.
Publicado: (2021)

Hydroxychloroquine reverses the prothrombotic state in a mouse model of antiphospholipid syndrome: Role of reduced inflammation and endothelial dysfunction
por: Miranda, Sébastien, et al.
Publicado: (2019)

Does Adjusted Global Antiphospholipid Syndrome Score (aGAPSS) Predict the Obstetric Outcome in Antiphospholipid Antibody Carriers? A Single-Center Study
por: Del Barrio-Longarela, Sara, et al.
Publicado: (2021)

Antiphospholipid antibodies increase the levels of mitochondrial DNA in placental extracellular vesicles: Alarmin-g for preeclampsia
por: Tong, Mancy, et al.
Publicado: (2017)

Gene expression profiling identifies distinct molecular signatures in thrombotic and obstetric antiphospholipid syndrome
por: Ripoll, Vera M., et al.
Publicado: (2018)

Purified IgG from Patients with Obstetric but not IgG from Non-obstetric Antiphospholipid Syndrome Inhibit Trophoblast Invasion
por: Poulton, Katie, et al.
Publicado: (2015)

Uterine metabolic disorder induced by silica nanoparticles: biodistribution and bioactivity revealed by labeling with FITC
por: Duan, Shuyin, et al.
Publicado: (2021)

Prevalence and diagnostic value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome in Chinese patients
por: Li, Siting, et al.
Publicado: (2023)

Hydroxychloroquine’s Probable Protective Effect in Liver injury among the COVID-19 Patients
por: Sima, Ali Reza
Publicado: (2021)

Immunoproteomic identification of anti-C9 autoimmune antibody in patients with seronegative obstetric antiphospholipid syndrome
por: Kuwabara, Yoshimitsu, et al.
Publicado: (2018)

Increased incidence of cancer in the follow-up of obstetric antiphospholipid syndrome within the NOH-APS cohort
por: Gris, Jean-Christophe, et al.
Publicado: (2020)

The Potential Benefit of Hydroxychloroquine in Chronic Placental Inflammation of Unknown Etiology Associated with Adverse Pregnancy Outcomes
por: Bouariu, Alexandra, et al.
Publicado: (2022)

Fetal Lung-Derived Exosomes in Term Labor Amniotic Fluid Induce Amniotic Membrane Senescence
por: Wan, Shuting, et al.
Publicado: (2022)

Protective effect of hydroxychloroquine on rheumatoid arthritis‐associated atherosclerosis
por: Shi, Na, et al.
Publicado: (2019)

Renal protective effect of antiplatelet therapy in antiphospholipid antibody-positive lupus nephritis patients without antiphospholipid syndrome
por: Hanaoka, Hironari, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_pd2ml8j1ialcqsria8imjm902g